[Emergency therapy in manifested shock].
D000138:Acidosis / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D002199:Capillary Permeability / Q000187:drug effects; D004630:Emergencies; D006336:Heart Massage; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D010952:Plasma Substitutes / Q000627:therapeutic use; D012121:Respiration, Artificial; D012769:Shock / Q000209:etiology / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000188:drug therapy / Q000628:therapy; D012771:Shock, Hemorrhagic / Q000188:drug therapy / Q000628:therapy; D012772:Shock, Septic / Q000628:therapy; D013148:Spironolactone / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D001639:Bicarbonates; D010952:Plasma Substitutes; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D013148:Spironolactone
Notfalltherapie beim manifesten Schock.